Correlation Between Iovance Biotherapeutics and Emergent Biosolutions
Can any of the company-specific risk be diversified away by investing in both Iovance Biotherapeutics and Emergent Biosolutions at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Iovance Biotherapeutics and Emergent Biosolutions into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Iovance Biotherapeutics and Emergent Biosolutions, you can compare the effects of market volatilities on Iovance Biotherapeutics and Emergent Biosolutions and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Iovance Biotherapeutics with a short position of Emergent Biosolutions. Check out your portfolio center. Please also check ongoing floating volatility patterns of Iovance Biotherapeutics and Emergent Biosolutions.
Diversification Opportunities for Iovance Biotherapeutics and Emergent Biosolutions
0.06 | Correlation Coefficient |
Significant diversification
The 3 months correlation between Iovance and Emergent is 0.06. Overlapping area represents the amount of risk that can be diversified away by holding Iovance Biotherapeutics and Emergent Biosolutions in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Emergent Biosolutions and Iovance Biotherapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Iovance Biotherapeutics are associated (or correlated) with Emergent Biosolutions. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Emergent Biosolutions has no effect on the direction of Iovance Biotherapeutics i.e., Iovance Biotherapeutics and Emergent Biosolutions go up and down completely randomly.
Pair Corralation between Iovance Biotherapeutics and Emergent Biosolutions
Given the investment horizon of 90 days Iovance Biotherapeutics is expected to under-perform the Emergent Biosolutions. But the stock apears to be less risky and, when comparing its historical volatility, Iovance Biotherapeutics is 1.46 times less risky than Emergent Biosolutions. The stock trades about -0.1 of its potential returns per unit of risk. The Emergent Biosolutions is currently generating about -0.03 of returns per unit of risk over similar time horizon. If you would invest 927.00 in Emergent Biosolutions on September 15, 2024 and sell it today you would lose (58.00) from holding Emergent Biosolutions or give up 6.26% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Iovance Biotherapeutics vs. Emergent Biosolutions
Performance |
| Timeline |
| Iovance Biotherapeutics |
| Emergent Biosolutions |
Iovance Biotherapeutics and Emergent Biosolutions Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Iovance Biotherapeutics and Emergent Biosolutions
The main advantage of trading using opposite Iovance Biotherapeutics and Emergent Biosolutions positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Iovance Biotherapeutics position performs unexpectedly, Emergent Biosolutions can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Emergent Biosolutions will offset losses from the drop in Emergent Biosolutions' long position.| Iovance Biotherapeutics vs. PTC Therapeutics | Iovance Biotherapeutics vs. Krystal Biotech | Iovance Biotherapeutics vs. Sarepta Therapeutics | Iovance Biotherapeutics vs. Madrigal Pharmaceuticals |
| Emergent Biosolutions vs. Puma Biotechnology | Emergent Biosolutions vs. Iovance Biotherapeutics | Emergent Biosolutions vs. Day One Biopharmaceuticals | Emergent Biosolutions vs. Inozyme Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.
Other Complementary Tools
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings |